您的位置: 首页 > 农业专利 > 详情页

Compositions and methods for tumor vaccination and immunotherapy involving HER antigens
专利权人:
Etubics Corporation
发明人:
Jones, Frank R.,Balint, Joseph,Gabitzsch, Elizabeth
申请号:
AU2018275147
公开号:
AU2018275147A1
申请日:
2018.06.02
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
In certain embodiments, methods and compositions are provided for generating immune responses against tumor antigens such as antigens or epitopes of HER1, HER2/neu, HER3, HER4, or any combination thereof. In particular embodiments, there may be provided methods for constructing and producing recombinant adenovirus-based vector vaccines containing nucleic acid sequences encoding tumor antigens such as antigens or epitopes of HER1, HER2/neu, HER3, HER4, or any combination thereof, that allow for vaccinations in individuals with preexisting immunity to adenovirus.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充